相关实验视频

Updated: Apr 11, 2026

Rapid Generation of Amyloid from Native Proteins In vitro

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

分子设计用于双调制粉样蛋白聚合效应的分子设计

Lijuan Zhu¹, Yang Song¹, Pin-Nan Cheng¹

¹Department of Chemistry and Materials Research Laboratory, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.

Journal of the American Chemical Society

|June 5, 2015

概括

研究人员开发了一种新型的聚乙烯胺-氨酸 (PEI-P) 结合物,可以调节粉样β (Aβ) 聚合. 这种合物加速中间形成,然后抑制纤维化,减少Aβ细胞毒性.

科学领域:

生物化学生物化学
分子生物学分子生物学
神经科学是一个神经科学.

背景情况:

蛋白质自我组装和粉样蛋白聚合在生物过程和疾病中至关重要.
目前粉样蛋白聚合的调节器通常提供简单的抑制或加速.
了解和控制粉样蛋白聚合对于治疗开发至关重要.

研究的目的:

为了引入一种新的多价值分子动机,聚乙烯胺-氨酸 (PEI-P) 结合物.
研究PEI-P结合物的双调制效应 (加速-抑制) 对粉样β (Aβ) 聚合的作用.
评估PEI-P结合物的对Aβ总细胞毒性的影响.

主要方法:

提奥夫拉T光测试用于监测聚合动力学.
循环二重化谱法用于分析二次结构变化.
原子力显微镜 (AFM) 用于可视化总体形态.
细胞活力测试以确定细胞毒性.

主要成果:

PEI-P结合物对Aβ聚合表现出剂量依赖的双调制效应.
结合剂加速了Aβ前纤维细胞中间体的形成.
随后,PEI-P合物抑制了Aβ纤维化,由于多价值性,与单独的珀芬相比,其疗效更强.
细胞活力测定证实在PEI-P结合物的存在下降了Aβ总细胞毒性.

结论:

PEI-P结合物代表了一种调节粉样蛋白聚合的新策略,具有双重加速抑制效应.
多价值增强PEI-P结合物的抑制能力.
这种方法为设计新型调节器提供了可概括的概念,以控制粉样蛋白聚合并减少相关的细胞毒性.

更多相关视频

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Amyloid Fibrils

Amyloid Fibrils

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...